SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-006425
Filing Date
2020-05-12
Accepted
2020-05-12 16:11:59
Documents
73
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q osmt-20200331x10q.htm 10-Q 1837576
2 EX-31.1 osmt-20200331ex3115c86a5.htm EX-31.1 12652
3 EX-31.2 osmt-20200331ex3124709eb.htm EX-31.2 12622
4 EX-32.1 osmt-20200331ex321f86fd4.htm EX-32.1 10162
5 EX-32.2 osmt-20200331ex322645f82.htm EX-32.2 11250
  Complete submission text file 0001558370-20-006425.txt   7592318

Data Files

Seq Description Document Type Size
6 EX-101.INS osmt-20200331.xml EX-101.INS 1881199
7 EX-101.SCH osmt-20200331.xsd EX-101.SCH 45728
8 EX-101.CAL osmt-20200331_cal.xml EX-101.CAL 56862
9 EX-101.DEF osmt-20200331_def.xml EX-101.DEF 180597
10 EX-101.LAB osmt-20200331_lab.xml EX-101.LAB 403089
11 EX-101.PRE osmt-20200331_pre.xml EX-101.PRE 333961
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Filer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-38709 | Film No.: 20869226
SIC: 2834 Pharmaceutical Preparations